CLINICAL_TRIALS trial_result · 2015-04-10

Clinical Trial Update: A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma [Phase 2]

A Phase II study in advanced renal cell carcinoma has completed. This entry serves as a trial update for the study.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Advanced Renal Cell Carcinoma | Phase 2 | Status: COMPLETED